Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alector, Inc. | President and Head of R&D | Common Stock | 592K | $2.89M | $4.88 | Oct 1, 2024 | Direct |
Unicycive Therapeutics, Inc. | Director | Stock Options | 180K | Sep 5, 2023 | Direct | ||
Alector, Inc. | President and Head of R&D | Employee Stock Option (right to buy) | 54.5K | Oct 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALEC | Alector, Inc. | Oct 1, 2024 | 1 | $0 | 4 | Oct 2, 2024 | President and Head of R&D |
ALEC | Alector, Inc. | Sep 3, 2024 | 1 | -$68K | 4 | Sep 4, 2024 | President and Head of R&D |
ALEC | Alector, Inc. | Jun 3, 2024 | 1 | -$63.4K | 4 | Jun 4, 2024 | President and Head of R&D |
ALEC | Alector, Inc. | Mar 4, 2024 | 1 | -$70.4K | 4 | Mar 5, 2024 | President and Head of R&D |
ALEC | Alector, Inc. | Dec 4, 2023 | 1 | -$69.6K | 4 | Dec 6, 2023 | President and Head of R&D |
ALEC | Alector, Inc. | Oct 1, 2023 | 2 | $0 | 4 | Oct 3, 2023 | President and Head of R&D |
UNCY | Unicycive Therapeutics, Inc. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | Director |
UNCY | Unicycive Therapeutics, Inc. | Sep 5, 2023 | 0 | $0 | 3 | Sep 7, 2023 | Director |
ALEC | Alector, Inc. | Sep 5, 2023 | 1 | -$32.3K | 4 | Sep 6, 2023 | President and Head of R&D |
ALEC | Alector, Inc. | Jun 2, 2023 | 1 | -$28.2K | 4 | Jun 5, 2023 | President and Head of R&D |
ALEC | Alector, Inc. | Mar 2, 2023 | 1 | -$84.2K | 4 | Mar 3, 2023 | President and Head of R&D |
ALEC | Alector, Inc. | Oct 1, 2022 | 2 | $0 | 4 | Oct 4, 2022 | President and Head of R&D |
ALEC | Alector, Inc. | Jan 3, 2022 | 3 | $0 | 4 | Jan 5, 2022 | President and Head of R&D |
ALEC | Alector, Inc. | Dec 15, 2021 | 0 | $0 | 3 | Dec 16, 2021 | President and Head of R&D |